The role of anti-glutamic acid decarboxylase autoantibodies (GAD-Ab) in idiopathic late onset cerebellar ataxia (ILOCA)

The role of anti-glutamic acid decarboxylase autoantibodies (GAD-Ab) in idiopathic late onset cerebellar ataxia (ILOCA)

Detalhes bibliográficos
Main Authors:	Muzaimi, M, McKnight, K, Lang, B, Wiles, M, Vincent, A, Robertson, N
Formato:	Conference item
Publicado em:	2004

Registos relacionados

Population-based perspective of anti-neuronal autoantibodies in patients with idiopathic late onset cerebellar ataxia (ILOCA)
Por: Muzaimi, M, et al.
Publicado em: (2004)

Role of antineuronal autoantibodies in population based samples of apparently idiopathic late onset cerebellar ataxia (ILOCA)
Por: Muzaimi, M, et al.
Publicado em: (2003)

Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
Por: Honnorat, J, et al.
Publicado em: (2001)

Autoantibody screening in subacute cerebellar ataxia.
Por: Trivedi, R, et al.
Publicado em: (2000)

Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia.
Por: Mirabelli-Badenier, M, et al.
Publicado em: (2012)

Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
Por: Stagg, C, et al.
Publicado em: (2010)

Cloning And Agrobacterium-Mediated Transformation Of Glutamate Decarboxylase (GAD) RNAi Construct In Eggplant (Solanum Melongena)
Por: Lee, Ze Hong
Publicado em: (2017)

Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.
Por: Chang, T, et al.
Publicado em: (2013)

Polymyoclonus, laryngospasm, and cerebellar ataxia associated with adenocarcinoma and multiple neural cation channel autoantibodies
Por: Lim, S., et al.
Publicado em: (2009)

SERUM AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE ARE ASSOCIATED WITH REDUCED CORTICAL GABA LEVELS IN PATIENTS WITH EPILEPSY
Por: Stagg, C, et al.
Publicado em: (2009)

Robotic compensation of cerebellar ataxia
Por: Smith, Eric D., S.M. Massachusetts Institute of Technology
Publicado em: (2008)

The future of diagnostics in Cerebellar Ataxias
Por: Nemeth, A
Publicado em: (2010)

Associative learning in patients with cerebellar ataxia.
Por: Tucker, J, et al.
Publicado em: (1996)

Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.
Por: Mehta, Z, et al.
Publicado em: (1999)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
Por: Turner, R, et al.
Publicado em: (1997)

New-onset focal epilepsy with palatal tremor and glutamic acid decarboxylase antibodies responding to intravenous immunoglobulin.
Por: Marnane, M, et al.
Publicado em: (2008)

Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
Por: Davison, L, et al.
Publicado em: (2008)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
Por: Becker, E, et al.
Publicado em: (2012)

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.
Por: Becker, E, et al.
Publicado em: (2012)

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
Por: Lorenzoni, P, et al.
Publicado em: (2008)

Do mutations in the murine ataxia gene TRPC3 cause cerebellar ataxia in humans?
Por: Fogel, B, et al.
Publicado em: (2015)

Purification and characterization of glutamate decarboxylase from Aspergillus oryzae NSK
Por: Lee, Audrey Ying Yeng
Publicado em: (2014)

Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia.
Por: Antozzi, C, et al.
Publicado em: (2005)

Candidate screening of the TRPC3 gene in cerebellar ataxia.
Por: Becker, E, et al.
Publicado em: (2011)

From Mice to Men: TRPC3 in Cerebellar Ataxia.
Por: Becker, E
Publicado em: (2015)

Candidate screening of the TRPC3 gene in cerebellar ataxia.
Por: Becker, E, et al.
Publicado em: (2011)

Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
Por: Clark, A, et al.
Publicado em: (2005)

Prevalence of glutamic acid decarboxylase antibodies amongst young Malaysian diabetics
Por: Nazaimoon, W.M.W., et al.
Publicado em: (1999)

Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
Por: Malter, M, et al.
Publicado em: (2010)

Genes for autosomal recessive cerebellar ataxia: order from chaos?
Por: Nemeth, A, et al.
Publicado em: (2001)

Serum glutamic acid decarboxylase 65 antibody levels in people with schizophrenia and their families.
Por: Gaughran, F, et al.
Publicado em: (2005)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
Por: Turner, R, et al.
Publicado em: (1997)

Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.
Por: Watson, L, et al.
Publicado em: (2015)

GAD antibodies in stiff-person syndrome.
Por: Chang, T, et al.
Publicado em: (2004)

Autosomal recessive cerebellar ataxia with oculomotor apraxia (ataxia-telangiectasia-like syndrome) is linked to chromosome 9q34.
Por: Németh, A, et al.
Publicado em: (2000)

Co-occurrence of acute ophthalmoplegia (without ataxia) and idiopathic intracranial hypertension
Por: Yeak, Justin, et al.
Publicado em: (2019)

Immunoprofiling of drug-resistant epilepsy with a focus on glutamic acid decarboxylase 65 antibodies
Por: McGinty, R
Publicado em: (2021)

The Moonwalker mouse: new insights into TRPC3 function, cerebellar development, and ataxia.
Por: Becker, E
Publicado em: (2014)

Recent advances in modelling of cerebellar ataxia using induced pluripotent stem cells
Por: Wong, M, et al.
Publicado em: (2017)

Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome
Por: Berridge, G, et al.
Publicado em: (2018)